Rep. Jefferson Shreve Purchases Shares of Agilent Technologies, Inc. (NYSE:A)

Representative Jefferson Shreve (R-Indiana) recently bought shares of Agilent Technologies, Inc. (NYSE:A). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $15,001 and $50,000 in Agilent Technologies stock on April 17th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account.

Representative Jefferson Shreve also recently made the following trade(s):

• Purchased $50,001 – $100,000 in shares of Chipotle Mexican Grill (NYSE:CMG) on 4/17/2025.
• Purchased $50,001 – $100,000 in shares of Applied Materials (NASDAQ:AMAT) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of Caterpillar (NYSE:CAT) on 4/17/2025.
• Sold $15,001 – $50,000 in shares of Lululemon Athletica (NASDAQ:LULU) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of Western Digital (NASDAQ:WDC) on 4/17/2025.
• Sold $15,001 – $50,000 in shares of Zoetis (NYSE:ZTS) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of Stryker (NYSE:SYK) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of NextEra Energy (NYSE:NEE) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of CSX (NASDAQ:CSX) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of Ross Stores (NASDAQ:ROST) on 4/17/2025.

Agilent Technologies Stock Down 1.6 %

Agilent Technologies stock opened at $106.93 on Friday. The company has a 50 day moving average of $111.53 and a 200-day moving average of $128.77. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $155.35. The stock has a market capitalization of $30.49 billion, a PE ratio of 24.58, a price-to-earnings-growth ratio of 3.01 and a beta of 1.27. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.54 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st were issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.93%. The ex-dividend date was Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.76%.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of the firm’s stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the transaction, the director now directly owns 35,737 shares of the company’s stock, valued at $4,161,931.02. This trade represents a 4.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Rodney Gonsalves sold 1,908 shares of the company’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now owns 21,786 shares in the company, valued at $2,657,456.28. This represents a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Hedge Funds Weigh In On Agilent Technologies

Several institutional investors have recently added to or reduced their stakes in the business. CKW Financial Group lifted its stake in shares of Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after buying an additional 100 shares in the last quarter. Global X Japan Co. Ltd. increased its holdings in Agilent Technologies by 161.1% during the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock worth $25,000 after buying an additional 116 shares during the last quarter. Redwood Park Advisors LLC bought a new stake in shares of Agilent Technologies in the 4th quarter worth approximately $27,000. Lee Danner & Bass Inc. bought a new stake in shares of Agilent Technologies in the fourth quarter valued at $29,000. Finally, Whipplewood Advisors LLC lifted its holdings in Agilent Technologies by 286.2% during the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock valued at $29,000 after purchasing an additional 186 shares during the last quarter.

Analyst Ratings Changes

Several equities analysts have recently weighed in on A shares. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating on the stock in a research report on Thursday, April 17th. Barclays dropped their price target on Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a research note on Thursday, April 10th. TD Cowen raised their target price on Agilent Technologies to $135.00 and gave the company a “buy” rating in a report on Thursday, April 10th. Robert W. Baird lowered their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research report on Thursday, February 27th. Finally, Jefferies Financial Group dropped their target price on Agilent Technologies from $135.00 to $116.00 and set a “hold” rating for the company in a research report on Monday, April 21st. Seven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $143.00.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana’s 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana’s 6th Congressional District. He declared candidacy for the 2026 election.

Email [email protected] to notify us of updates to this biography.
Jefferson Shreve earned a bachelor’s degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve’s career experience includes working as a real estate executive.

Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.